Jacobson Schmitt Advisors buys $4,787,474 stake in AmerisourceBergen Corp. (ABC)

AmerisourceBergen Corp. (ABC) : Jacobson Schmitt Advisors scooped up 23,725 additional shares in AmerisourceBergen Corp. during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 3, 2016. The investment management firm now holds a total of 62,565 shares of AmerisourceBergen Corp. which is valued at $4,787,474.AmerisourceBergen Corp. makes up approximately 4.22% of Jacobson Schmitt Advisors’s portfolio.

Other Hedge Funds, Including , Columbus Circle Investors sold out all of its stake in ABC during the most recent quarter. The investment firm sold 771,479 shares of ABC which is valued $59,033,573.Evercore Wealth Management boosted its stake in ABC in the latest quarter, The investment management firm added 103 additional shares and now holds a total of 18,519 shares of AmerisourceBergen Corp. which is valued at $1,417,074. AmerisourceBergen Corp. makes up approx 0.06% of Evercore Wealth Management’s portfolio.Aperio Group reduced its stake in ABC by selling 13,188 shares or 9.43% in the most recent quarter. The Hedge Fund company now holds 126,656 shares of ABC which is valued at $10,778,426. AmerisourceBergen Corp. makes up approx 0.09% of Aperio Group’s portfolio. Candriam Luxembourg S.c.a. added ABC to its portfolio by purchasing 31,775 company shares during the most recent quarter which is valued at $2,704,053. AmerisourceBergen Corp. makes up approx 0.07% of Candriam Luxembourg S.c.a.’s portfolio. Fox Run Management L.l.c. sold out all of its stake in ABC during the most recent quarter. The investment firm sold 2,400 shares of ABC which is valued $220,536.

AmerisourceBergen Corp. closed down -0.69 points or -0.89% at $76.68 with 36,83,560 shares getting traded on Tuesday. Post opening the session at $77.78, the shares hit an intraday low of $76.4 and an intraday high of $78.2887 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, AmerisourceBergen Corp. reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 5, 2016. Analyst had a consensus of $1.58. The company had revenue of $35698.36 million for the quarter, compared to analysts expectations of $35804.35 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Shares were Reiterated by RBC Capital Mkts on May 6, 2016 to “Outperform” and Lowered the Price Target to $ 85 from a previous price target of $100 .Shares were Reiterated by FBR Capital on May 6, 2016 to “Mkt Perform” and Lowered the Price Target to $ 84 from a previous price target of $100 .AmerisourceBergen Corp. was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.